HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Esther Oliva Selected Research

Smooth Muscle Tumor

11/2014Müllerian adenosarcoma of the uterus with low-grade sarcomatous overgrowth characterized by prominent hydropic change resulting in mimicry of a smooth muscle tumor.
1/2009Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
4/2002An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Esther Oliva Research Topics

Disease

50Neoplasms (Cancer)
01/2016 - 01/2002
18Carcinoma (Carcinomatosis)
10/2015 - 02/2002
11Endometrial Neoplasms (Endometrial Cancer)
04/2015 - 01/2005
7Ovarian Neoplasms (Ovarian Cancer)
12/2014 - 01/2003
7Endometrial Stromal Sarcoma
07/2014 - 01/2002
7Adenocarcinoma
05/2011 - 02/2002
6Leiomyosarcoma
10/2014 - 04/2002
5Endometrioid Carcinoma
11/2013 - 01/2005
4Neoplasm Metastasis (Metastasis)
04/2015 - 01/2005
3Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)
12/2015 - 01/2005
3Leiomyoma (Uterine Fibroids)
11/2014 - 04/2002
3Smooth Muscle Tumor
11/2014 - 04/2002
3Carcinosarcoma
05/2013 - 01/2011
3Wilms Tumor (Wilm's Tumor)
01/2011 - 11/2003
3Endometrial Stromal Tumors
03/2009 - 04/2002
3Renal Cell Carcinoma (Grawitz Tumor)
11/2008 - 01/2005
3Metaplasia
10/2005 - 01/2002
2Testicular Neoplasms (Testicular Cancer)
09/2015 - 02/2013
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2015 - 02/2012
2Confusion (Bewilderment)
10/2014 - 04/2002
2Angiomyolipoma
10/2013 - 03/2011
2Infection
05/2013 - 11/2010
2Necrosis
05/2013 - 03/2010
2Sarcoma (Soft Tissue Sarcoma)
10/2012 - 05/2006
2Anoxia (Hypoxia)
02/2012 - 06/2011
2Microsatellite Instability
08/2009 - 10/2005
2Multiple Myeloma
03/2005 - 11/2002
2Transitional Cell Carcinoma
01/2003 - 02/2002
1Sertoli-Leydig Cell Tumor
12/2015
1Hyperplasia
10/2015
1Pain (Aches)
03/2015
1Adenosarcoma
11/2014
1Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
07/2014
1Leiomyomatosis
07/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
02/2014
1Lymphoma (Lymphomas)
05/2013
1Neuroblastoma
05/2013

Drug/Important Bio-Agent (IBA)

7Inhibins (Inhibin)IBA
10/2015 - 04/2002
7calretininIBA
10/2015 - 01/2005
7DesminIBA
07/2015 - 01/2002
7AntibodiesIBA
05/2014 - 04/2002
7Keratins (Keratin)IBA
05/2013 - 02/2002
6Cyclin D1IBA
10/2015 - 05/2012
6ParaffinIBA
10/2015 - 01/2003
5Calmodulin-Binding Proteins (Caldesmon)IBA
07/2015 - 04/2002
5Estrogens (Estrogen)FDA Link
05/2012 - 01/2005
5beta CateninIBA
08/2009 - 01/2005
4VimentinIBA
10/2015 - 01/2002
4Biological Markers (Surrogate Marker)IBA
04/2015 - 11/2010
3tebufenozide (Mimic)IBA
10/2014 - 06/2004
3Cadherins (E-Cadherin)IBA
11/2013 - 10/2010
3Phosphotransferases (Kinase)IBA
05/2013 - 10/2005
3Eosine Yellowish-(YS) (Eosin)IBA
05/2013 - 06/2004
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
05/2013 - 10/2005
3Hematoxylin (Haematoxylon)IBA
05/2013 - 06/2004
3DNA (Deoxyribonucleic Acid)IBA
05/2011 - 03/2010
3Mucin-1 (CA 15-3 Antigen)IBA
12/2010 - 02/2005
3N-methylsuccinimideIBA
08/2009 - 10/2005
3Messenger RNA (mRNA)IBA
02/2008 - 09/2003
3alpha-methylacyl-CoA racemaseIBA
01/2007 - 06/2004
3ThrombomodulinIBA
01/2005 - 01/2003
3uroplakin IIIIBA
01/2005 - 01/2003
3Paclitaxel (Taxol)FDA LinkGeneric
04/2004 - 06/2002
2MART-1 AntigenIBA
01/2016 - 12/2010
2CyclinsIBA
05/2014 - 10/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2013 - 05/2006
2tyrosine receptor (receptor, tyrosine)IBA
05/2013 - 10/2005
2MicroRNAs (MicroRNA)IBA
02/2013 - 01/2011
2Progesterone Receptors (Progesterone Receptor)IBA
05/2012 - 01/2011
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2010 - 03/2006
2Histone Deacetylases (Histone Deacetylase)IBA
12/2010 - 03/2006
2Keratin-7 (Cytokeratin 7)IBA
01/2007 - 11/2003
2Transcription Factors (Transcription Factor)IBA
10/2006 - 01/2005
2Keratin-20 (Cytokeratin 20)IBA
11/2003 - 01/2003
1tranilast (N 5')IBA
12/2015
1Formaldehyde (Formol)FDA Link
10/2015
1MyogeninIBA
07/2015
1MyoglobinIBA
07/2015
1lenalidomide (CC 5013)FDA Link
03/2015
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2015
1Ovarian epithelial cancerIBA
12/2014
1Adenosarcoma of the uterusIBA
11/2014
16-bromo-2-naphthyl sulfate (BNS)IBA
10/2014
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
07/2014
1Succinate Dehydrogenase (Fumarate Reductase)IBA
07/2014
1Immunoconjugates (Immunoconjugate)IBA
03/2014
1OsteonectinIBA
11/2013
1CytokinesIBA
10/2013
1ChemokinesIBA
10/2013
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2013
1Threonine (L-Threonine)FDA Link
05/2013
1methionylmethionine (Met-Met)IBA
05/2013

Therapy/Procedure

5Hysterectomy
11/2014 - 01/2002
4Drug Therapy (Chemotherapy)
04/2015 - 06/2002
2Cystectomy
02/2014 - 05/2013
2Heterologous Transplantation (Xenotransplantation)
10/2013 - 09/2003
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
03/2005 - 11/2002
1Orchiectomy (Orchidectomy)
09/2015
1Adjuvant Chemotherapy
02/2014
1Nephrectomy
10/2013